We live in an era of medical miracles. From antibiotics that cure deadly infections to targeted therapies that shrink tumors, modern medicine feels like magic. But behind every pill in your cabinet and every injection at the doctor’s office lies a rigorous, complex, and often decades-long journey.
Key insight: A very potent drug isn't always the best drug. Sometimes a partial effect (e.g., for blood pressure) prevents overshoot.
Let's follow the pharmacological tasks through each clinical phase.
In this post, we explore the indispensable role of pharmacology throughout the drug discovery and development pipeline.
: The relative ability of a drug to produce a biological response once bound. Mechanistic Modeling : Modern drug discovery utilizes Pharmacokinetic-Pharmacodynamic (PK/PD)
Case in point: Beta-blockers (like propranolol) are antagonists at beta-adrenergic receptors. Their PD profile—specifically, their ability to block adrenaline without activating the receptor—lowers heart rate and blood pressure. A molecule with slightly different PD properties (partial agonism) would fail as a beta-blocker.
Distribution: Where does the drug go? After absorption, the drug travels via blood. Barriers exist. The blood-brain barrier (BBB) is a formidable lipophilic wall. A drug targeting a brain tumor (e.g., for glioblastoma) must be lipid-soluble enough to cross the BBB, yet water-soluble enough to travel in plasma.
The process begins with target identification, where pharmacologists identify biological components like receptors, enzymes, or genes that are believed to cause a disease.
We live in an era of medical miracles. From antibiotics that cure deadly infections to targeted therapies that shrink tumors, modern medicine feels like magic. But behind every pill in your cabinet and every injection at the doctor’s office lies a rigorous, complex, and often decades-long journey.
Key insight: A very potent drug isn't always the best drug. Sometimes a partial effect (e.g., for blood pressure) prevents overshoot.
Let's follow the pharmacological tasks through each clinical phase. pharmacology in drug discovery and development
In this post, we explore the indispensable role of pharmacology throughout the drug discovery and development pipeline.
: The relative ability of a drug to produce a biological response once bound. Mechanistic Modeling : Modern drug discovery utilizes Pharmacokinetic-Pharmacodynamic (PK/PD) The Engine of Medicine: The Vital Role of
Case in point: Beta-blockers (like propranolol) are antagonists at beta-adrenergic receptors. Their PD profile—specifically, their ability to block adrenaline without activating the receptor—lowers heart rate and blood pressure. A molecule with slightly different PD properties (partial agonism) would fail as a beta-blocker.
Distribution: Where does the drug go? After absorption, the drug travels via blood. Barriers exist. The blood-brain barrier (BBB) is a formidable lipophilic wall. A drug targeting a brain tumor (e.g., for glioblastoma) must be lipid-soluble enough to cross the BBB, yet water-soluble enough to travel in plasma. pharmacology in drug discovery and development
The process begins with target identification, where pharmacologists identify biological components like receptors, enzymes, or genes that are believed to cause a disease.
